Ichikawa T, Kitajima S, Liang J, Koike T, Wang X, Sun H, Okazaki M, Morimoto M, Shikama H, Watanabe T, et al
In June 2021, Wegovy was approved for chronic weight management in patients with: A body mass index (BMI) of 27 kg/m 2 or greater with at least one weight-related condition, like high blood pressure, type 2 diabetes, or high cholesterol A BMI of 30 kg/m 2 or greater How Does Wegovy Work
A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy
Who Should Not Undergo This Procedure Based on current clinical understanding, IV glutathione infusions are generally not appropriate for: Individuals who are pregnant or breastfeeding Patients with a history of kidney or liver disease Those with a known allergy to glutathione, ascorbic acid (Vitamin C), or any other component of the infusion Individuals with certain autoimmune or haematological conditions these should be assessed and discussed with a doctor Comparing IV Glutathione to Evidence-Based Skin-Brightening Treatments For patients with concerns about skin tone, hyperpigmentation, melasma, post-inflammatory hyperpigmentation (PIH), or solar lentigines, a range of treatments with a more established evidence base are available in Singapore